Physician
Kids Clinic Pediatric and Adolescent Medicine
Kids Clinic Pediatric and Adolescent Medicine was paid $7.26M by Medicaid between Oct 2018 and Dec 2024, across 75 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 82% of everything it billed.
33Billing provider infoKIDS CLINIC PEDIATRIC AND ADOLESCENT MEDICINE
TALLADEGA, AL 35160
TALLADEGA, AL 35160
33aNPI1154810224assigned 05/04/2018
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$7.26M
24GClaims202,455
24DCodes billed75
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Alabama
Rank by total paid#2 of 21
Median peer was paid$270K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,626 | $81K | |
| 2019 | 37,266 | $762K | |
| 2020 | 23,866 | $885K | |
| 2021 | 33,896 | $1.52M | |
| 2022 | 41,792 | $1.40M | |
| 2023 | 36,544 | $1.32M | |
| 2024incomplete | 24,465 | $1.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 82% | 50,837 | 35,838 | $5.96M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.8% | 2,019 | 1,721 | $346K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.0% | 22,833 | 17,279 | $219K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.0% | 13,781 | 6,973 | $147K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 35,219 | 27,232 | $130K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.6% | 6,061 | 4,525 | $120K |
| 87632 | <1% | 604 | 536 | $57K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 563 | 449 | $21K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 669 | 553 | $19K |
| 87486 | <1% | 605 | 537 | $14K | |
| 87581 | <1% | 605 | 537 | $14K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 568 | 531 | $14K |
63 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 603 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,310 | $13K |
| 80061 | Lipid panel | <1% | 1,109 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,950 | $12K |
| 92551 | <1% | 3,620 | $12K | |
| 99173 | <1% | 3,754 | $11K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 3,264 | $10K |
| 99000 | <1% | 13,478 | $10K | |
| 36416 | <1% | 5,511 | $10K | |
| 90670 | <1% | 1,552 | $9K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,415 | $7K |
| 90698 | <1% | 1,196 | $7K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,009 | $7K |
| 90680 | <1% | 922 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,603 | $5K |
| 90716 | <1% | 720 | $4K | |
| 90707 | <1% | 706 | $4K | |
| 83655 | <1% | 400 | $4K | |
| 90744 | <1% | 625 | $4K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,712 | $4K |
| 90651 | <1% | 597 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,031 | $3K |
| 90633 | <1% | 375 | $2K | |
| 90734 | <1% | 341 | $2K | |
| 90677 | <1% | 257 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,877 | $2K |
| 81002 | <1% | 934 | $2K | |
| 99383 | <1% | 107 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 311 | $1K |
| 99384 | <1% | 57 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,902 | $1K |
| 90715 | <1% | 201 | $1K | |
| 86403 | <1% | 420 | $804.53 | |
| 87807 | <1% | 96 | $781.00 | |
| 92579 | <1% | 96 | $741.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 601 | $738.25 |
| 86328 | <1% | 27 | $728.18 | |
| 90686 | <1% | 114 | $688.00 | |
| 90672 | <1% | 158 | $640.00 | |
| 90696 | <1% | 118 | $560.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 734 | $546.00 |
| 85018 | <1% | 813 | $414.00 | |
| 90697 | <1% | 100 | $368.00 | |
| 90648 | <1% | 50 | $368.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 80 | $342.00 |
| 92575 | <1% | 92 | $306.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 530 | $305.00 |
| 90461 | <1% | 1,135 | $304.80 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,069 | $219.12 |
| 90661 | <1% | 16 | $120.00 | |
| 90685 | <1% | 134 | $120.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 25 | $100.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 141 | $99.92 |
| 90688 | <1% | 37 | $32.00 | |
| 94664 | <1% | 89 | $10.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 242 | $0.00 |
| 90474 | 0% | 47 | $0.00 | |
| 94760 | 0% | 65 | $0.00 | |
| 87276 | 0% | 86 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 104 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 233 | $0.00 |
| 90473 | 0% | 109 | $0.00 | |
| 87275 | 0% | 81 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIDDIQUI, MUHAMMED (OWNER)